Ventricular Assist Devices Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The report covers Ventricular Assist Device Market Trends & Companies and the market is segmented by Type of Ventricular Device (Left Ventricular Assist Device (LVAD), Right Ventricular Assist Device (RVAD), Biventricular Assist Device (BIVAD)), Application (Bridge-to-transplant (BTT) therapy, Destination therapy, and Other Therapies), and Geography (North America, Europe, Asia-Pacific, Middle East & Africa, and South America). The market provides the value (in USD million) for the above-mentioned segments.

Ventricular Assist Devices Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Ventricular Assist Device Market Size

Ventricular Assist Device Market Summary
Study Period 2019 - 2030
Base Year For Estimation 2024
Forecast Data Period 2025 - 2030
Historical Data Period 2019 - 2023
CAGR 7.23 %
Fastest Growing Market Asia Pacific
Largest Market North America

Major Players

Ventricular Assist Device Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Global Ventricular Assist Device Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Ventricular Assist Device Market Analysis

The Global Ventricular Assist Device Market is expected to register a CAGR of 7.23% during the forecast period.

COVID-19 is expected to have a significant impact on the growth of the market. According to the article titled ' Implantation of Durable VAD during COVID-19: An Epicenter Experience' published in 2021 new technological advances and creativity from the team allowed for the successful implantation of urgent Destination Therapy-Ventricular Assist Devices during the COVID-19 pandemic. Hence, the onset of the pandemic allowed various modifications to the existing process which are needed to accommodate a safe and comprehensive ventricular assist device plan. Thus, the ventricular assist device market is significantly impacted by COVID-19.

The major factors attributing to the growth of the ventricular assist device market are technological advancement of devices for cardiac disease management, growing initiatives and awareness regarding cardiovascular diseases, and the increasing burden of cardiac diseases and heart failure. According to the World Health Organization 2021, an estimated 17.9 million people die due to cardiovascular diseases worldwide, each year. This represents 35% of global deaths. Additionally, 85% of these cardiovascular disease deaths are due to heart attack and stroke. In addition, according to the article published in Cureus Journal of Medical Science in July 2020, ischemic heart disease (IHD) is a leading cause of death worldwide. Ischemic heart disease affects around 126 million individuals (1,655 per 100,000) globally, which is approximately 1.72% of the world's population. The global prevalence of ischemic heart disease is expected to exceed 1,845 per 100,000 by the year 2030.

VAD implantations are lifesaving equipment for patients with severe heart failure. They are useful in minimizing the symptoms of heart failure, thus helping patients to resume their daily activities. Coronary heart diseases associated with hypertension are a very common cause of chronic heart failure. Apart from that, other cardiac conditions, such as ischaemic and dilated cardiomyopathies, also require a significant level of surgical interventions. For all patient cases requiring advanced heart failure-related therapy, heart transplantation is a long-term successful procedure.

However, due to less availability of organs, the waiting time is more than six months. Such cases require the immediate assistance of VAD, which acts as a bridge to transplantation. Here, the demand for, and availability of, VAD plays a critical role, and thus, the growing burden of cardiac diseases and heart failure is a major force in propelling the VAD market at the global level. However, there are also risks involved in the VAD implant, hence these risks are showing an impact on the market growth.

Ventricular Assist Device Industry Overview

The ventricular assist device market is moderately competitive and consists of several major players. In terms of market share, few of the major players currently dominate the market. With the rising geriatric population and high prevalence of diseases, few other smaller players are expected to enter into the market in the coming years. Some of the major players of the market are Abiomed Inc., BiVACOR Inc, Abbott Laboratories (St. Jude Medical Inc.), Medtronic PLC, and Terumo Corporation, among others.

Ventricular Assist Device Market Leaders

  1. Abiomed Inc.

  2. BiVACOR Inc.

  3. Abbott Laboratories (St. Jude Medical Inc.)

  4. Medtronic PLC

  5. Terumo Corporation

  6. *Disclaimer: Major Players sorted in no particular order
Ventricular Assist Device Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

Ventricular Assist Device Market News

  • In January 2022, the School of Medical Research and Technology (SMRT) of IIT Kanpur has launched Hridyantra, a challenge-based program to develop an advanced artificial heart also called Left Ventricular Assist device (LVAD) for patients with end-stage heart failure.
  • In June 2021, Abbott announced the company has the capacity and supply to effectively support the growing demand for mechanical circulatory support (MCS) devices for the effective treatment of advanced heart failure following Medtronic's decision to stop the global distribution and sale of the Medtronic HeartWare ventricular assist device (HVAD).

Ventricular Assist Device Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing Burden of Cardiac Diseases and Heart Failure
    • 4.2.2 Technological Advancement of Devices for Cardiac Diseases Management
    • 4.2.3 Growing Initiatives and Awareness Regarding Cardiovascular Diseases
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Devices and Procedures
    • 4.3.2 Several Risks Associated to VAD Implant
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Type of Ventricular Device
    • 5.1.1 Left Ventricular Assist Device (LVAD)
    • 5.1.2 Right Ventricular Assist Device (RVAD)
    • 5.1.3 Biventricular Assist Device (BIVAD)
  • 5.2 By Application
    • 5.2.1 Bridge-to-transplant (BTT) Therapy
    • 5.2.2 Destination Therapy
    • 5.2.3 Other Therapies
  • 5.3 Geography
    • 5.3.1 North America
    • 5.3.1.1 United States
    • 5.3.1.2 Canada
    • 5.3.1.3 Mexico
    • 5.3.2 Europe
    • 5.3.2.1 Germany
    • 5.3.2.2 United Kingdom
    • 5.3.2.3 France
    • 5.3.2.4 Italy
    • 5.3.2.5 Spain
    • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
    • 5.3.3.1 China
    • 5.3.3.2 Japan
    • 5.3.3.3 India
    • 5.3.3.4 Australia
    • 5.3.3.5 South Korea
    • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East & Africa
    • 5.3.4.1 GCC
    • 5.3.4.2 South Africa
    • 5.3.4.3 Rest of Middle East & Africa
    • 5.3.5 South America
    • 5.3.5.1 Brazil
    • 5.3.5.2 Argentina
    • 5.3.5.3 Rest of South America

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Abiomed Inc.
    • 6.1.2 BiVACOR Inc.
    • 6.1.3 Abbott Laboratories (St. Jude Medical Inc.)
    • 6.1.4 Berlin Heart GmbH
    • 6.1.5 Calon Cardio
    • 6.1.6 Jarvik Heart Inc.
    • 6.1.7 Medtronic PLC
    • 6.1.8 SynCardia Systems LLC
    • 6.1.9 Terumo Corporation
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape Covers- Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Ventricular Assist Device Industry Segmentation

As per the scope, ventricular assist devices (VAD) are highly important for patients with weakened hearts or heart failures. They are used to temporarily maintain the heart function, until the heart recovers, or before the heart transplant. In some chronic heart conditions, they are used as permanent support therapy, as they are mechanical pumps that are surgically implanted in the heart to pump blood into the whole body. The Ventricular Assist Device Market is segmented by Type of Ventricular Device (Left Ventricular Assist Device (LVAD), Right Ventricular Assist Device (RVAD), Biventricular Assist Device (BIVAD)), Application (Bridge-to-transplant (BTT) therapy, Destination therapy, and Other Therapies), and Geography (North America, Europe, Asia-Pacific, Middle East & Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions, globally. The report offers the value (in USD million) for the above segments.

By Type of Ventricular Device Left Ventricular Assist Device (LVAD)
Right Ventricular Assist Device (RVAD)
Biventricular Assist Device (BIVAD)
By Application Bridge-to-transplant (BTT) Therapy
Destination Therapy
Other Therapies
Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa GCC
South Africa
Rest of Middle East & Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

Ventricular Assist Device Market Research FAQs

What is the current Global Ventricular Assist Device Market size?

The Global Ventricular Assist Device Market is projected to register a CAGR of 7.23% during the forecast period (2025-2030)

Who are the key players in Global Ventricular Assist Device Market?

Abiomed Inc., BiVACOR Inc., Abbott Laboratories (St. Jude Medical Inc.), Medtronic PLC and Terumo Corporation are the major companies operating in the Global Ventricular Assist Device Market.

Which is the fastest growing region in Global Ventricular Assist Device Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in Global Ventricular Assist Device Market?

In 2025, the North America accounts for the largest market share in Global Ventricular Assist Device Market.

What years does this Global Ventricular Assist Device Market cover?

The report covers the Global Ventricular Assist Device Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Global Ventricular Assist Device Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Ventricular Assist Devices Industry Report

Statistics for the 2025 Global Ventricular Assist Device market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Global Ventricular Assist Device analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.